DR. RECKEWEG R34 Calcossin

Product NDC: 53346-1334
11-digit product format: 533461334
Labeler code: 53346
Product ID: 53346-1334_b3d3c578-4872-4a94-80e1-bcaf42087ed9
Type: HUMAN OTC DRUG
Nonproprietary name: Calcarea carbonica 30X, Calcarea fluorica 12X, Calcarea hypophosphorosa 6X, Calcarea phosphorica 12X, Chamomilla 6X, Hekla Lava 12X, Mercurius praecipitatus ruber 12X, Mezereum 6X, Silicea 30X
Dosage form: LIQUID
Route: ORAL
Labeler: PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start: 1986-06-01
Marketing end: 0000-00-00
Substance: OYSTER SHELL CALCIUM CARBONATE, CRUDE; CALCIUM FLUORIDE; CALCIUM HYPOPHOSPHITE; CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE; MATRICARIA RECUTITA; HEKLA LAVA; MERCURIC OXIDE; DAPHNE MEZEREUM BARK; SILICON DIOXIDE
Active strength: 30 [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	53346-1334		I	Inactivated by FDA		2026-09-14
excluded package	package	53346-1334	53346-1334-5	I	Inactivated by FDA		2026-09-14

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53346-1334-5	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53346-1334-5	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53346-1334-5	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53346-1334-5	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53346-1334-5	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53346-1334-5	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53346-1334-5	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53346-1334-5	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53346-1334-5	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	53346-1334-5	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	53346-1334-5	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	53346-1334-5	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	53346-1334-5	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	53346-1334-5	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	53346-1334-5	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	53346-1334-5	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	53346-1334-5	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	53346-1334-5	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	53346-1334-5	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53346-1334-5	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53346-1334-5	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	53346-1334-5	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bee4fa8d-8d82-423a-a0b5-40a89dd13a99	Product name	1	20250618
e0d2eb29-08bd-4bba-90d1-c91c68a38767	Product name	4	20250516
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2	Product name	5	20250304
334fe8d2-68fb-4331-a576-420e302ec069	Product name	7	20240320
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
e92765c1-be81-432a-b909-1b10777ec378	Product name	1	20190208
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
0441a8f5-3835-497c-aedd-bc78cba56b2a	Product name	1	20150317
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
53346-1334-5	2020-01-31	C162847	48780-1	9d75b9d1-0c03-f424-e053-dadaa90a57ce	DR. RECKEWEG R34 Calcossin

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53346-1334-5	DR. RECKEWEG R34 CalcossinCombination Product	50 mL in 1 BOTTLE	LIQUID	50		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CALCIUM FLUORIDE	ACTIVE INGREDIENT	O3B55K4YKI	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
CALCIUM HYPOPHOSPHITE	ACTIVE INGREDIENT	CUI83R2732	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE	ACTIVE INGREDIENT	O7TSZ97GEP	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
DAPHNE MEZEREUM BARK	ACTIVE INGREDIENT	X2N6E405GV	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
HEKLA LAVA	ACTIVE INGREDIENT	C21158IIRK	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
MATRICARIA RECUTITA	ACTIVE INGREDIENT	G0R4UBI2ZZ	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
MERCURIC OXIDE	ACTIVE INGREDIENT	IY191986AO	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
OYSTER SHELL CALCIUM CARBONATE, CRUDE	ACTIVE INGREDIENT	2E32821G6I	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
SILICON DIOXIDE	ACTIVE INGREDIENT	ETJ7Z6XBU4	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
CALCIUM CATION	ACTIVE MOIETY	2M83C4R6ZB	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	ACTIVE MOIETY	L11K75P92J	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
DAPHNE MEZEREUM BARK	ACTIVE MOIETY	X2N6E405GV	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
FLUORIDE ION	ACTIVE MOIETY	Q80VPU408O	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
HEKLA LAVA	ACTIVE MOIETY	C21158IIRK	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
MATRICARIA RECUTITA	ACTIVE MOIETY	G0R4UBI2ZZ	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
MERCURIC OXIDE	ACTIVE MOIETY	IY191986AO	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
OYSTER SHELL CALCIUM CARBONATE, CRUDE	ACTIVE MOIETY	2E32821G6I	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
SILICON DIOXIDE	ACTIVE MOIETY	ETJ7Z6XBU4	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53346-1334	DR. RECKEWEG R34 CALCOSSIN COMBINATION PRODUCT (CALCAREA CARBONICA 30X, CALCAREA FLUORICA 12X, CALCAREA HYPOPHOSPHOROSA 6X, CALCAREA PHOSPHORICA 12X, CHAMOMILLA 6X, HEKLA LAVA 12X, MERCURIUS PRAECIPITATUS RUBER 12X, MEZEREUM 6X, SILICEA 30X) LIQUID [PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO]	1	Legacy NDC, 1 package rows	20130514_eaa57f2e-c76e-440a-8062-805b31f0f51f.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
2E32821G6I	OYSTER SHELL CALCIUM CARBONATE, CRUDE		OYSTER SHELL CALCIUM CARBONATE, CRUDE
O3B55K4YKI	CALCIUM FLUORIDE	7789-75-5	CALCIUM FLUORIDE
CUI83R2732	CALCIUM HYPOPHOSPHITE	7789-79-9	CALCIUM HYPOPHOSPHITE
C21158IIRK	HEKLA LAVA		HEKLA LAVA
IY191986AO	MERCURIC OXIDE	21908-53-2	MERCURIC OXIDE
X2N6E405GV	DAPHNE MEZEREUM BARK		DAPHNE MEZEREUM BARK
ETJ7Z6XBU4	SILICON DIOXIDE	7631-86-9	SILICON DIOXIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
53346-1334-5	53346133405	50 mL in 1 BOTTLE	50 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
DR. RECKEWEG R34 Calcossin	PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO	2013-04-04	HUMAN OTC DRUG LABEL	1